Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Androidâ„¢ device!
Free
Faster access than browser!
 

BRAF (gene) and MEK inhibitor

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between BRAF (gene) and MEK inhibitor

BRAF (gene) vs. MEK inhibitor

BRAF is a human gene that encodes a protein called B-Raf. A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.

Similarities between BRAF (gene) and MEK inhibitor

BRAF (gene) and MEK inhibitor have 8 things in common (in Unionpedia): BRAF (gene), Colorectal cancer, Dabrafenib, MAPK/ERK pathway, Melanoma, Mitogen-activated protein kinase kinase, Non-small-cell lung carcinoma, Vemurafenib.

BRAF (gene)

BRAF is a human gene that encodes a protein called B-Raf.

BRAF (gene) and BRAF (gene) · BRAF (gene) and MEK inhibitor · See more »

Colorectal cancer

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).

BRAF (gene) and Colorectal cancer · Colorectal cancer and MEK inhibitor · See more »

Dabrafenib

Dabrafenib (trade name Tafinlar, GSK2118436) is a drug for the treatment of cancers associated with a mutated version of the gene BRAF.

BRAF (gene) and Dabrafenib · Dabrafenib and MEK inhibitor · See more »

MAPK/ERK pathway

The MAPK/ERK pathway (also known as the Ras-Raf-MEK-ERK pathway) is a chain of proteins in the cell that communicates a signal from a receptor on the surface of the cell to the DNA in the nucleus of the cell.

BRAF (gene) and MAPK/ERK pathway · MAPK/ERK pathway and MEK inhibitor · See more »

Melanoma

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes.

BRAF (gene) and Melanoma · MEK inhibitor and Melanoma · See more »

Mitogen-activated protein kinase kinase

Mitogen-activated protein kinase kinase (also known as MAP2K, MEK, MAPKK) is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK).

BRAF (gene) and Mitogen-activated protein kinase kinase · MEK inhibitor and Mitogen-activated protein kinase kinase · See more »

Non-small-cell lung carcinoma

Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC).

BRAF (gene) and Non-small-cell lung carcinoma · MEK inhibitor and Non-small-cell lung carcinoma · See more »

Vemurafenib

Vemurafenib (INN, marketed as Zelboraf) is a B-Raf enzyme inhibitor developed by Plexxikon (now part of Daiichi-Sankyo) and Genentech for the treatment of late-stage melanoma.

BRAF (gene) and Vemurafenib · MEK inhibitor and Vemurafenib · See more »

The list above answers the following questions

BRAF (gene) and MEK inhibitor Comparison

BRAF (gene) has 133 relations, while MEK inhibitor has 20. As they have in common 8, the Jaccard index is 5.23% = 8 / (133 + 20).

References

This article shows the relationship between BRAF (gene) and MEK inhibitor. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »